Blog

The case for patient-controlled rare disease data across science, policy, and the lived experience.

Featured

Patient Experience

What the system tells us

Nine sentences inherited from a different era.

Read →

This week

Patient Experience

What we still have to do

The structural friction of rare disease daily life.

Read →

Data Sovereignty

Unpaid data farmers

The data work we have been doing for free, finally compensated.

Read →

Vision

The flywheel

Cohort proof licensed. Contribution measured. Deposit lands.

Read →

Search articles

Browse by tag

Clear ×

Patient Experience Data Sovereignty Vision Science & Data Regulatory Ultra-rare Accelerating innovation Ehlers-Danlos Newborn screening Company History

Read all41 of 117 · Tag: Newborn screening

May 7, 2026Glutaric acidemia I and the striatumNewborn screening
May 7, 2026The C5-OH clusterNewborn screening
May 7, 2026Isovaleric acidemia, the genotype-phenotype questionNewborn screening
May 7, 2026The fatty acid oxidation familyNewborn screening
May 7, 2026Carnitine uptake defectNewborn screening
May 7, 2026LCHAD deficiencyNewborn screening
May 7, 2026Trifunctional protein deficiencyNewborn screening
May 7, 2026VLCADD, the three phenotypesNewborn screening
May 7, 2026Hearing loss, the other newborn screenNewborn screening
May 7, 2026Propionic acidemia, the cardiomyopathy the screen cannot preventNewborn screening
May 7, 2026Methylmalonic acidemia, mutase deficiencyNewborn screening
May 7, 2026Methylmalonic acidemia, cobalamin disordersNewborn screening
May 7, 2026Argininosuccinic aciduriaNewborn screening
May 7, 2026Citrullinemia type INewborn screening
May 7, 2026Hurler syndrome, the bone marrow transplant pioneerNewborn screening
May 7, 2026Hunter syndrome, the blood-brain barrier problemNewborn screening
May 7, 2026GAMT, the third OTC supplement treatmentNewborn screening
May 7, 2026Hemoglobin SC, the quieter sickle variantNewborn screening
May 7, 2026Sickle beta-thalassemia, the third formNewborn screening
May 7, 2026CCHD, the screen without a blood spotNewborn screening
May 7, 2026Duchenne, the other disorder waiting for the panelNewborn screening
May 7, 2026CAH, the endocrine emergency the screen preventsNewborn screening
May 7, 2026Tyrosinemia type I, the drug that rewrote the prognosisNewborn screening
May 7, 2026Homocystinuria, the vitamin-responsive amino acid disorderNewborn screening
May 7, 2026Krabbe disease and the screen that runs out of timeNewborn screening
May 7, 2026X-ALD, from Lorenzo's oil to gene therapyNewborn screening
May 7, 2026Biotinidase deficiency, the vitamin that prevents deafnessNewborn screening
May 7, 2026Cystic fibrosis, the poster child grows upNewborn screening
May 7, 2026Metachromatic leukodystrophy, the four million dollar treatment that needs screeningNewborn screening
May 7, 2026PKU in the developing worldNewborn screening
May 7, 2026The Screening Success Nobody Talks AboutNewborn screening
May 7, 2026When Perfect Compliance Is Not EnoughNewborn screening
May 7, 2026The Babies Whose Deaths Were Blamed on Their ParentsNewborn screening
May 7, 2026The Mennonite ClinicNewborn screening
May 7, 2026The Mothers Who Built Newborn ScreeningNewborn screening
May 7, 2026Bubble Boy to Population Screening in One GenerationNewborn screening
May 7, 2026Race, Screening, and the $2 Million CureNewborn screening
May 7, 2026The Father Who Became a Biotech CEONewborn screening
May 7, 2026The Most Expensive Drug and the Argument for SpeedNewborn screening
Apr 28, 2026PKU formula, a logistics primerNewborn screening
Apr 28, 2026What is newborn screening, in plain wordsNewborn screening